Hint mode is switched on Switch off

BioAge Labs, ordinary share
BIOA, US09077V1008

Add a stock to WL
Choose all Reset all
BioAge Labs, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
BioAge Labs, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. BioAge Labs serves customers worldwide.
  • Issuer
  • Full borrower / issuer name
    BioAge Labs, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    BIOA
  • Placement
    26.09.2024
  • Lock up period
    180
  • Number of papers
    11,000,000
  • Volume of raised funds
    198 mln USD
  • Placement share
    32.19%
  • Final placement price
    18 USD
  • Price change since placement date
    -34.89%
  • By capitalization
    615.01 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    BIOA
  • Placement
    22.01.2026
  • Lock up period
    180
  • Number of papers
    5,897,435
  • Volume of raised funds
    115 mln USD
  • Placement share
    14.13%
  • Final placement price
    19.5 USD
  • Price change since placement date
    -39.9%
  • By capitalization
    814.08 mln USD

IFRS/US GAAP reports

2026
II q eng
2025
I q eng
II q eng
III q eng
2024
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

24/03/2026 BioAge Labs: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
21/01/2026 BioAge Labs: Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits
04/12/2025 BioAge Labs: Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
05/06/2025 BioAge Labs: Submission Of Matters To A Vote Of Security Holders
04/06/2025 BioAge Labs: Other Events
All organization news

Holders

Industry Leaders

Registration is required to get access.